ENTITY
Hugel Inc

Hugel Inc (145020 KS)

76
Analysis
Health Care • South Korea
Hugel, Inc. is a Bio-pharmaceutical company that focuses on developing beauty/cosmetics related products. The Company's main products include botulinum toxin and fillers.
more
bullish•Hugel Inc
•10 Nov 2025 19:54•Broker

Hugel (145020 KQ/Buy)Overseas Revenue Growth Is Key

For 3Q25, Hugel reported below-consensus results, with revenue of W105.9bn (+0.8% YoY) and operating profit of W47.4bn (-11.2% YoY).

Logo
256 Views
Share
•02 Oct 2025 07:01•Broker

Equity Strategy[October] Reduced Earnings Volatility Is the Key to a Re-Rating

The 3Q25 earnings season is set to kick off following the Chuseok holiday. The consensus for Korean companies’ aggregate operating profit stands at...

Logo
345 Views
Share
bullish•Hugel Inc
•07 Aug 2025 19:58•Broker

Hugel (145020 KQ Aug 5, 2025) - Buy the Dip on 2Q Results

Reiterate BUY, with TP unchanged at W470,000. Share price remains cheap; potential pullbacks on concerns over 2Q earnings should rather offer entry...

Logo
208 Views
Share
x